tiprankstipranks
Molecular Partners AG (MLLCF)
OTHER OTC:MLLCF
US Market
MLLCF
Molecular Partners AG
RESEARCH TOOLSreports

Molecular Partners AG (MLLCF) Stock News & Sentiment

10 Followers
Molecular Partners: Buy Rating Reaffirmed on Pipeline Progress and Cash Runway, $12 Price Target Unchanged
Premium
Ratings
Molecular Partners: Buy Rating Reaffirmed on Pipeline Progress and Cash Runway, $12 Price Target Unchanged
19d ago
MOLN
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
Premium
Ratings
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
1M ago
MOLN
Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
Premium
Ratings
Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
3M ago
MOLN
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
Premium
Ratings
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
3M ago
MOLN
Buy Recommendation on Molecular Partners: Advancing Radio-DARPin Platform, Strategic Isotope Collaboration, and Cash Runway Through 2028 Underpin Attractive Risk‑Reward
Premium
Ratings
Buy Recommendation on Molecular Partners: Advancing Radio-DARPin Platform, Strategic Isotope Collaboration, and Cash Runway Through 2028 Underpin Attractive Risk‑Reward
3M ago
MOLN
Buy Rating on Molecular Partners: Expanding Radiopharmaceutical Platform, Isotope Partnership, and Flexible DARPin Strategy Support Favorable Risk-Reward
Premium
Ratings
Buy Rating on Molecular Partners: Expanding Radiopharmaceutical Platform, Isotope Partnership, and Flexible DARPin Strategy Support Favorable Risk-Reward
3M ago
MOLN
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
Premium
Company Announcements
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
5M ago
MLLCF
More MLLCF News >

MLLCF News on the Web

Molecular Partners AG at TD Cowen Oncology Innovation Summit (Virtual) Transcript
GuruFocus News
Neutral
Molecular Partners announces presentation of preclinical data at AACR
TipRanks News
Bullish
Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
TipRanks News
Bullish
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
TipRanks News
Bullish
Buy Recommendation on Molecular Partners: Advancing Radio-DARPin Platform, Strategic Isotope Collaboration, and Cash Runway Through 2028 Underpin Attractive Risk‑Reward
TipRanks News
Bullish
Molecular Partners (MOLN) Gets a Buy from Clear Street
TipRanks News
Bullish
Buy Rating on Molecular Partners: Expanding Radiopharmaceutical Platform, Isotope Partnership, and Flexible DARPin Strategy Support Favorable Risk-Reward
TipRanks News
Bullish
Molecular Partners enters Radio-DARPin therapeutics pact with Eckert & Ziegler
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MLLCF
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.5 articles
News Sentiment
This Week50%
Sector Average82%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MLLCF’s Media Buzz Sentiment?
1 articles about MLLCF were published this week. In an average week, 0.5 articles are published.
    What is MLLCF’s weekly average amount of articles?
    In an average week, 0.5 articles about MLLCF are published.
      What is MLLCF’s News Sentiment?
      50% of articles about MLLCF were positive this week, compared to its sector average of 82%.
        Healthcare Stocks that are Trending in the News
        AAgilent
        PHRPhreesia
        ADOAnteoTech Ltd
        OTLKOutlook Therapeutics
        IHHHFIHH Healthcare Bhd
        Showing the stocks with the most bullish news sentiment over the past week